
-
AI video becomes more convincing, rattling creative industry
-
Trump says new tariff deadline 'not 100 percent firm'
-
Trump hosts Netanyahu in push for Gaza deal
-
Alpha males are rare among our fellow primates: scientists
-
At least 10 dead in Kenya during protests after heavy police deployment
-
Alcaraz, Sabalenka headline action in Wimbledon quarter-finals
-
Trump unveils first wave of steeper US tariffs, extends deadline
-
Knicks hire two-time NBA Coach of the Year Brown to guide club
-
Medical groups sue US health secretary over Covid-19 vaccine change
-
Now 48, man becomes 140th 'stolen grandchild' tracked in Argentina
-
Sinner wins Wimbledon reprieve after Dimitrov injury heartbreak, Djokovic survives
-
Trump unveils first wave of steeper US tariffs in push for deals
-
Swiss MLS goalie Frei resting at home after on-field collision
-
Relentless Spain reach Euro 2025 quarters after thumping Belgium
-
US stocks retreat from records on Trump tariff deluge
-
MLB Nationals name Cairo interim manager after shake-up
-
Sinner into Wimbledon quarter-finals after injury heartbreak for Dimitrov
-
Pacers guard Haliburton will miss entire '25-26 NBA season
-
Texas floods: How geography, climate and policy failures collided
-
Sinner into Wimbledon quarters after injured Dimitrov retires
-
UN General Assembly condemns 'systematic oppression' of women in Afghanistan
-
Epstein died by suicide, did not have 'client list': govt memo
-
Trump, Brazil's Lula clash over politically charged coup trial
-
Trump to meet Netanyahu in push for Gaza deal
-
Swiatek into Wimbledon quarter-finals
-
High-speed fall forces Philipsen out of Tour de France
-
Trump says to slap allies Japan, South Korea with 25% tariffs
-
Maresca shrugs off heat concerns as Chelsea face 'ugly duckling' Fluminense
-
Youth camp confirms 27 dead as Texas flood toll passes 90
-
US revoking 'terrorist' designation for Syria's HTS
-
Trump threatens allies Japan, South Korea with 25% tariffs
-
Relentless Spain thump Belgium to close in on Euro 2025 quarters
-
Wimbledon changes line-calling system after embarrassing blunder
-
France backs returning colonial-era 'talking drum' to I.Coast
-
King hails 'spirit of unity' as Britain remembers 7/7 attacks
-
US measles epidemic its worst of 21st century
-
Djokovic survives scare to reach Wimbledon quarters, Sinner in action
-
Looted art: the battle for looted treasures
-
Trump slaps allies Japan, South Korea with 25% tariffs
-
Belgian Merlier wins crash-marred Tour de France dash to Dunkirk
-
Celebs light up Schiaparelli to open Paris Haute Couture Week
-
Youth camp confirms 27 dead as Texas flood toll nears 90
-
Respect for Lara stops Mulder short of world Test record
-
Mexico president slams xenophobia after anti-gentrification protest
-
Djokovic stays on track for Wimbledon glory under Federer gaze
-
Belgian Merlier wins crash-marred Tour de France stage
-
Djokovic battles back against De Minaur to stay on track for Wimbledon glory
-
Israel, Hamas hold indirect talks ahead of Netanyahu-Trump meet
-
Trump steps up pressure for deals as US tariff deadline nears
-
Iran president says Israel attempted to assassinate him

'Synthetic embryo' breakthrough but growing human organs far off
Stem cell scientists say they have created "synthetic embryos" without using sperm, eggs or fertilisation for the first time, but the prospect of using such a technique to grow human organs for transplantation remains distant.
The breakthrough was hailed as a major step forward, though some experts said the result could not fully be considered to be embryos and warned of future ethical considerations.
In research published in the journal Cell this week, scientists at the Weizmann Institute of Science in Israel described mouse stem cells self-assembling into embryo-like structures in the lab.
The research built upon 2018 research that had a bundle of mouse stem cells self-organised into something resembling the beginnings of an embryo -- but with far fewer cells.
The Weizmann team led by Palestinian stem cell scientist Jacob Hanna went much further.
They started by collecting cells from the skin of mice, then made them artificially return to the state of stem cells.
The stem cells were then placed in a special incubator, which continuously moved to mimic a mother's womb.
The vast majority of the cells failed to form anything.
But 50 -- 0.5 percent of the 10,000 total -- collected themselves into spheres, then embryo-like structures, the researchers said.
After eight days -- around a third of the 20-day mouse gestation period -- there were early signs of a brain and a beating heart, they added.
They were described as 95 percent similar to normal mouse embryos.
"The embryo is the best organ-making machine and the best 3D bioprinter -- we tried to emulate what it does," Hanna said in a Weizmann statement.
- 'Not embryos' -
While they were the most advanced synthetic embryo-like structures ever grown, some scientists not involved in the research warned against calling them "embryos".
"These are not embryos," French stem cell scientist Laurent David told AFP.
"Until proven otherwise, they do not result in a viable individual capable of reproducing," he added.
He preferred to call them embryoids, the name for a group of cells that resemble an embryo, emphasising that they showed only the very beginnings of organs.
However, David welcomed the "very convincing" research, which he said could allow further experiments to understand exactly how organs form.
Hanna said the team's "next challenge is to understand how stem cells know what to do -- how they self-assemble into organs and find their way to their assigned spots inside an embryo".
- Ethical implications -
If human organs could one day be grown in a lab, it could provide life-saving transplants to thousands of people every year without the need for donors.
There has been progress in this new field -- several years ago researchers managed to develop an artificial intestine in the lab that could be implanted into a mouse.
For humans, however, such organ implants remain science fiction.
Still, Hanna has founded a company, Renewal Bio, that aims to find a way to use the technology for therapeutic purposes.
Researchers not involved in the study said it was very early to consider using such a technique for humans.
Alfonso Martinez Arias of Spain's Pompeu Fabra University said the breakthrough "opens the door to similar studies with human cells, though there are many regulatory hoops to get through first and, from the point of view of the experiments, human systems lag behind mouse systems".
And aiming to get similar results from human cells will likely open an ethical can of worms.
"Although the prospect of synthetic human embryos is still distant, it will be crucial to engage in wider discussions about the legal and ethical implications of such research," James Briscoe of Britain's Francis Crick Institute said.
H.E.Young--AMWN